[1] |
PATEL T.Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States[J].Hepatology, 2001, 33(6):1353. doi: 10.1053/jhep.2001.25087 |
[2] |
XIANG S, LAU WY, CHEN XP.Hilar cholangiocarcinoma:controversies on the extent of surgical resection aiming at cure[J].Int J Colorectal Dis, 2015, 30(2):159. doi: 10.1007/s00384-014-2063-z |
[3] |
LENDVAI G, SZEKERCZES T, ILLYES I, et al.Cholangiocarcinoma:Classification, Histopathology and Molecular Carcinogenesis[J].Pathol Oncol Res, 2020, 26(1):3. doi: 10.1007/s12253-018-0491-8 |
[4] |
RIZVI S, KHAN SA, HALLEMEIER CL, et al.Cholangiocarcinoma-evolving concepts and therapeutic strategies[J].Nat Rev Clin Oncol, 2018, 15(2):95. doi: 10.1038/nrclinonc.2017.157 |
[5] |
PU LZ, SINGH R, LOONG CK, et al.Malignant Biliary Obstruction:Evidence for Best Practice[J].Gastroenterol Res Pract, 2016, 2016:3296801. |
[6] |
BLECHACZ B.Cholangiocarcinoma:current knowledge and new developments[J].Gut Liver, 2017, 11(1):13. doi: 10.5009/gnl15568 |
[7] |
KHAN SA, DAVIDSON BR, GOLDIN RD, et al.Guidelines for the diagnosis and treatment of cholangiocarcinoma:an update[J].Gut, 2012, 61(12):1657. doi: 10.1136/gutjnl-2011-301748 |
[8] |
LABIB PL, DAVIDSON BR, SHARMA RA, et al.Locoregional therapies in cholangiocarcinoma[J].Hepat Oncol, 2017, 4(4):99. doi: 10.2217/hep-2017-0014 |
[9] |
DELEON TT, AHN DH, BOGENBERGER JM, et al.Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma[J].Future Oncol, 2018, 14(6):553. doi: 10.2217/fon-2017-0451 |
[10] |
TANG Z, YANG Y, MENG W, et al.Best option for preoperative biliary drainage in Klatskin tumor:a systematic review and meta-analysis[J].Medicine (Baltimore), 2017, 96(43):e8372. doi: 10.1097/MD.0000000000008372 |
[11] |
WORLD MEDICAL A.World Medical Association Declaration of Helsinki:ethical principles for medical research involving human subjects[J].JAMA, 2013, 310(20):2191. doi: 10.1001/jama.2013.281053 |
[12] |
胡小四, 庞青, 刘会春, 等.125I粒子腔内照射联合瘤体内粒子植入治疗局部进展期胰头癌[J].中国微创外科杂志, 2019, 19(9):794. |
[13] |
HU X, PANG Q, LIU H, et al.Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with (125)I seeds intracavitary irradiation[J].Clin Transl Oncol, 2019, 21(5):665. doi: 10.1007/s12094-018-1969-2 |
[14] |
PANG Q, ZHOU L, HU XS, et al.Biliary stenting alone versus biliary stenting combined with (125)I particles intracavitary irradiation for the treatment of advanced cholangiocarcinoma[J].Sci Rep, 2019, 9(1):11348. doi: 10.1038/s41598-019-47791-4 |
[15] |
SQUADRONI M, TONDULLI L, GATTA G, et al.Cholangiocarcinoma[J].Crit Rev Oncol Hematol, 2017, 116:11. doi: 10.1016/j.critrevonc.2016.11.012 |
[16] |
KADABA RS, BOWERS KA, KHORSANDI S, et al.Complications of biliary-enteric anastomoses[J].Ann R Coll Surg Engl, 2017, 99(3):210. doi: 10.1308/rcsann.2016.0293 |
[17] |
SON RC, GWON DI, KO HK, et al.Percutaneous unilateral biliary metallic stent placement in patients with malignant obstruction of the biliary hila and contralateral portal vein steno-occlusion[J].Korean J Radiol, 2015, 16(3):586. doi: 10.3348/kjr.2015.16.3.586 |
[18] |
RAZUMILAVA N, GORES GJ.Classification, diagnosis, and management of cholangiocarcinoma[J].Clin Gastroenterol Hepatol, 2013, 11(1):13. |
[19] |
ZHU HD, GUO JH, HUANG M, et al.Irradiation stents vs.conventional metal stents for unresectable malignant biliary obstruction:a multicentre trial[J].J Hepatol, 2018, 68(5):970. doi: 10.1016/j.jhep.2017.12.028 |
[20] |
QIU H, JI J, SHAO Z, et al.The efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in treatment of advanced lung cancer:a meta-analysis[J].J Coll Physicians Surg Pak, 2017, 27(4):237. |
[21] |
HASIMU A, GU JP, JI WZ, et al.Comparative study of percutaneous transhepatic biliary stent placement with or without Iodine-125 seeds for treating patients with malignant biliary obstruction[J].J Vasc Interv Radiol, 2017, 28(4):583. doi: 10.1016/j.jvir.2016.11.038 |
[22] |
XU X, LI J, WU J, et al.A systematic review and meta-analysis of intraluminal brachytherapy versus stent alone in the treatment of malignant wbstructive jaundice[J].Cardiovasc Intervent Radiol, 2018, 41(2):206. doi: 10.1007/s00270-017-1827-6 |
[23] |
LI M, LI K, QI X, et al.Percutaneous transhepatic biliary stent implantation for obstructive jaundice of perihilar cholangiocarcinoma:a prospective study on predictors of stent patency and survival in 92 patients[J].J Vasc Interv Radiol, 2016, 27(7):1047. doi: 10.1016/j.jvir.2016.02.035 |
[24] |
FORSMARK CE, DINIZ AL, ZHU AX.Consensus conference on hilar cholangiocarcinoma[J].HPB (Oxford), 2015, 17(8):666. doi: 10.1111/hpb.12451 |
[25] |
RAZUMILAVA N, GLEESON FC, GORES GJ.Awareness of tract seeding with endoscopic ultrasound tissue acquisition in perihilar cholangiocarcinoma[J].Am J Gastroenterol, 2015, 110(1):200. |
[26] |
NAVANEETHAN U, HASAN MK, LOURDUSAMY V, et al.Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures:a systematic review[J].Gastrointest Endosc, 2015, 82(4):608. doi: 10.1016/j.gie.2015.04.030 |